ANXA1 is reported as a positive regulator of EphA2 in Nasopharyngeal Carcinoma, gastric and colon cancer, targeting which can decrease EphA2 protein to suppress the cancer cells63, 64. The gene discussed is EPHA2; the disease is nasopharyngeal carcinoma.